![]()
|
|
||||||||
J. Biol. Chem., Vol. 266, Issue 15, 9617-9621, May, 1991
MC Birchenall-Roberts, LA Falk, J Kasper, J Keller, CR Faltynek and FW Ruscetti
Transforming growth factor-beta 1 (TGF-beta 1) is a pleiotropic polypeptide
hormone known to play an important role as a modulator of hematopoietic
processes in human and murine cells. One of the characteristics of TGF-beta
1 is the ability to inhibit the growth of several cell types, including
cells of the myeloid lineage. To study the mechanism by which TGF-beta 1
inhibits the growth of myeloid cells, we have used three murine myeloid
cell lines, the parental interleukin- 3-dependent 32D-123 cell line and two
retrovirally infected interleukin- 3-independent cell lines (32D-abl,
32D-src), all of which are growth inhibited by TGF-beta 1. Each of these
oncogene-transfected cells expresses a greater number of TGF-beta 1
receptors than the parental cell line and responds to TGF-beta 1 with
increased sensitivity; 32D and 32D-src cells are 2- and 58-fold more
sensitive to TGF-beta 1 inhibition than the parental cell line (ED50 = 35
pM). Both 32D-abl- and 32D-src-transformed cell lines expressed higher
levels of the 65- and 85-kDa TGF-beta 1 receptor species than did the
parental cells. We observed a correlation between the greater sensitivity
of 32D-src cells to TGF-beta 1 and the more rapid down-modulation and
reappearance of cell surface TGF-beta 1 receptors on 32D-src cells. Thus,
the level of TGF-beta 1 receptor expression and rate of reexpression both
have a crucial regulatory effect on the functional activity of the TGF-beta
1 ligand.
Differential expression of transforming growth factor-beta 1 (TGF-beta 1) receptors in murine myeloid cell lines transformed with oncogenes. Correlation with differential growth inhibition by TGF-beta 1
Laboratory of Molecular Immunoregulation, National Cancer Institute, Frederick Cancer Research and Development Center, Maryland 21702-1201.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S. H. Park, M. C. Birchenall-Roberts, Y. Yi, B. I. Lee, D. K. Lee, D. C. Bertolette, T. Fu, F. Ruscetti, and S.-J. Kim Mechanism of Induction of Transforming Growth Factor-{beta} Type II Receptor Gene Expression by v-Src in Murine Myeloid Cells Cell Growth Differ., January 1, 2001; 12(1): 9 - 18. [Abstract] [Full Text] |
||||
![]() |
O.-S. Bang, F. W. Ruscetti, M.-H. Lee, S.-J. Kim, and M. C. Birchenall-Roberts Transforming Growth Factor-beta1 Modulates p107 Function in Myeloid Cells J. Biol. Chem., March 29, 1996; 271(13): 7811 - 7819. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Bae, A. G. Geiser, D. H. Kim, M. T. Chung, J. K. Burmester, M. B. Sporn, A. B. Roberts, and S.-J. Kim Characterization of the Promoter Region of the Human Transforming Growth Factor-beta Type II Receptor Gene J. Biol. Chem., December 8, 1995; 270(49): 29460 - 29468. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |